Fig. 2
From: Exosomal DNAJB11 promotes the development of pancreatic cancer by modulating the EGFR/MAPK pathway
DNAJB11 expression is elevated in pancreatic cancer tissues and associated with a poor prognosis. A Expression levels of DNAJB11 in most cancers, as shown by the TCGA database. B DNAJB11 exhibits significantly higher expression in pancreatic cancer than in healthy individuals. C Higher DNAJB11 showed a poorer survival rate in patients with pancreatic cancer. D Alterations in DNAJB11 were less correlated with RFS in patients with pancreatic cancer. E Representative images of DNAJB11 staining in tumor tissues and adjacent tissues (AT). Scoring for the IHC is indicated. F Overall survival analysis of patients with pancreatic cancer with DNAJB11 expression by Kaplan–Meier analysis with log-rank test (**P < 0.01). G Multivariate cox proportional hazard analyses revealed that advanced TNM stage DNAJB11 expression contributed to poor OS